Related Experiment Video
Updated: Dec 29, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.1K
The Need for Disruptive Innovation in Pharmacy
1Creighton University, School of Pharmacy and Health Professions, Omaha, Nebraska.
American Journal of Pharmaceutical Education
|February 1, 2020
Summary
Disruptive innovation offers new opportunities for pharmacy practice and education. This commentary explores barriers and requirements for implementing these innovations to advance the field.
Area of Science:
- Pharmacy
- Business Management
- Innovation Studies
Background:
- The concept of disruptive innovation emerged in the business sector in the mid-1990s.
- Pharmacy practice and education are evolving, necessitating an examination of innovative models.
- Understanding disruptive innovation is crucial for the future of pharmaceutical services.
Purpose of the Study:
- To apply the concept of disruptive innovation to the field of pharmacy.
- To analyze the current state of pharmacy education and practice in relation to innovation.
- To identify barriers and requirements for successful disruptive innovation in pharmacy.
Main Methods:
- Commentary and analysis of existing literature and industry trends.
- Discussion of the applicability of business innovation models to pharmacy.
- Identification of key factors influencing innovation adoption in pharmaceutical settings.
Main Results:
- Pharmacy faces unique challenges and opportunities in adopting disruptive innovations.
- Specific barriers include regulatory hurdles, established practices, and educational inertia.
- Key requirements involve strategic planning, stakeholder engagement, and a culture shift.
Conclusions:
- Disruptive innovation holds significant potential to transform pharmacy education and practice.
- Overcoming identified barriers is essential for realizing future innovative opportunities.
- Proactive adaptation and strategic implementation are vital for the advancement of pharmacy.
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
114
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
114
01:02Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
160
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
160
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
138
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
138
01:19Nonlinear Pharmacokinetics: Overview
970
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
970
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K